First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors
Clinical trial NCT02160106 · COMPLETED
Trial details
- NCT number
- NCT02160106
- Sponsor
- MedPacto, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-29
- Primary completion
- 2018-07-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.